In July 2012 the Fédération Internationale de Volleyball (FIVB), the International Volleyball Federation, has reported an anti-doping rule violation against the Indian Athlete Kumar Umang after his A and B samples tested positive for the prohibited substance 19-norandrostenedione (nandrolone). After notification the FIVB ordered a provisional suspension. The Athlete submitted a medical prescription without further explanations in his defence and he failed to be heard for the FIVB Anti-Doping Hearing Panel.
The Hearing Panel has serious doubt about the authenticity of the prescription, submitted by the Athlete, which also doesn’t explain the prohibited substance found in his sample.
Therefore the FIVB Anti-Doping Hearing Panel decides on 28 November 2011 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 31 july 2012.
